BNET Industries
Last Fiscal Year Sales:$31.1M
- Public
- US
Dow Jones Description
Third Wave Technologies, Inc. is a leading molecular diagnostics company. We believe our proprietary Invader chemistry, a novel, molecular chemistry, is easier to use and more accurate than competing technologies. These and other advantages conferred by our chemistry enable us to provide clinicians and researchers with superior molecular solutions. More than 230 clinical laboratory customers are using Third Waves molecular diagnostic reagents. Other customers include pharmaceutical and biotechnology companies, academic research centers and major health care providers. Currently, one of our key strategic initiatives is the commercialization of our Human Papillomavirus (HPV) offering. In August 2006, we began clinical trials for two HPV pre-market approval submissions to the FDA. We expect to spend $18 million on these submissions over three years, however, this amount could vary pending FDA review and ongoing trial performance. In March 2008, we disclosed the achievement of positive clinical trial data, in which we achieved all primary clinical endpoints in the clinical trial for our human papillomavirus (HPV) tests. The Company submitted the pre-market approval application to the U.S. Food and Drug Administration for both its high-risk and 16/18 genotyping products in April 2008. If for any reason we are unable to successfully commercialize our HPV offering, our business and prospects would likely be materially adversely impacted. ...
President & CEO
Kevin ConroyNumber of Employees 179
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Badger State's tech boom
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Kevin Conroy | President & CEO |
| Chris Burton | Senior Vice President Sales & Marketing |
| Ivan Trifunovich | Senior Vice President |
| Jorge A. Garces | Senior Vice President R&D |
| Gregory Hamilton | Vice President, Finance and Operations |
| John Bellano | Vice President, Sales |
| John Ballano | |
| G. Burrill | Director |
| Sam Eletr | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Dan Broderick | Board of Directors |
| David A. Thompson | Board of Directors |
| Gorden F. Brunner | Board of Directors |
| James J. Herrmann | Board of Directors |
| Kay Napier | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | President & CEO | Current |
| EXACT Sciences Corporation | President and Chief Executive Officer | Current |
| EXACT Sciences Corporation | President, Chief Executive | Former |
| Thirdwave, LLC | President | Former |
| Third Wave Technologies, Inc. | Chief Executive | Former |
| Thirdwave, LLC | Chief Executive | Former |
| EXACT Sciences Corporation | Vice President | Former |
| Thirdwave, LLC | Vice President of Legal Affairs | Former |
| McDermott Will & Emery | intellectual property litigator | Former |
| Pattishall | Property Litigator | Former |
| GE Healthcare | Former | |
| Michigan State University | Bachelor's Degree In Electrical Engineering | Former |
| University of Michigan | Degree | Former |
| EXACT Sciences Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Senior Vice President Sales & Marketing | Current |
Ivan D. Trifunovich, Ph.D. (43) , joined us as Senior Vice President in December 2001. Dr. Trifunovich previously held successive positions as Vice President of e-Business and Vice President of Research Strategy and Operations at Pharmacia Corp. Prior to joining Pharmacia, Dr. Trifunovich was a Director of New Product Marketing at Johnson & Johnson, Inc. He began his career at Bristol-Meyers Squibb, Inc. as a bench scientist, where he held several positions of increasing responsibility. Dr. Trifunovich received his Ph.D. in organic chemistry at UCLA and an M.B.A. at the University of Pennsylvania s Wharton School of Business. He is the holder of 10 U.S. patents.
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Senior Vice President | Current |
| Crosslink Genetics Corp. | A. Senior Vice President and General Manager, Third Wave Technologies | Current |
| Pharmacia Corporation | Vice President of Research Strategy and Operations | Former |
| Johnson & Johnson | Director of New Product Marketing | Former |
| Bristol-Myers Squibb Company | Scientist | Former |
| University of California, Los Angeles | Ph.D. In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Senior Vice President R&D | Current |
| Thirdwave, LLC | Executive Director of Clinical Development | Current |
| Third Wave Technologies, Inc. | Vice President, Research and Development | Former |
| Genzyme Corporation | Vice President, Research and Development | Former |
| Genzyme Corporation | Executive Director | Former |
| Genzyme Genetics | Director of Molecular Research and Development | Former |
| Athena Diagnostics, Inc. | Associate Product Manager | Former |
| Athena Diagnostics, Inc. | Research and Development Scientist | Former |
| Proteome, Inc. | Scientist | Former |
| Genzyme Corporation | Director | Former |
| City University of New York | Doctorate In Cell | Former |
| Brooklyn College | Bachelor's Degree In Biology | Former |
| University of Massachusetts Medical School | Postdoctoral | Former |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Vice President, Finance and Operations | Current |
| Thirdwave, LLC | Executive Director | Current |
| Planning Ltd. | Executive Director | Current |
| Organization | Position | Status |
|---|---|---|
| Thirdwave, LLC | Regional Vice President of Sales | Current |
| Third Wave Technologies, Inc. | Vice President, Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Current | |
| Roche Diagnostics Corporation | Former | |
| Abbott Laboratories | Former |
| Organization | Position | Status |
|---|---|---|
| Deltanoid Pharmaceuticals Inc | Managing Director | Current |
| Prolog Ventures | Managing Director | Current |
| Venture Investors LLC | Co-Founder | Current |
| Pro-Log | Venture Partner | Current |
| Zystor Therapeutics, Inc | Mason | Current |
| Tandem Press | Current | |
| University of Wisconsin | Current | |
| Prolog Ventures | Board of Directors | Current |
| Zystor Therapeutics, Inc | Board of Directors | Current |
| Asoyia | Board of Directors | Current |
| CS-Keys, Inc. | Board of Directors | Current |
| TomoTherapy Incorporated | Board of Directors | Current |
| Third Wave Technologies, Inc. | Board of Directors | Current |
| Deltanoid Pharmaceuticals Inc | Board of Directors | Current |
| Eragen Biosciences, Inc. | Board of Directors | Current |
| Mason Wells | Managing Director | Former |
| Prolog Ventures | Partner | Former |
| Mayo Clinic | Director of the Office of Technology Commercialization | Former |
| Mayo Clinic | Appointment to the Staff | Former |
| Deltanoid Pharmaceuticals Inc | Mason | Former |
| Mezzia, Inc. | Director | Former |
| The Wisconsin Technology Council | Board of Directors | Former |
| Gala Design | Director | Former |
| University of Wisconsin-Madison | Ms In Marketing and Finance | Former |
| University of Utah | Bs In Finance | Former |
| Iowa State University | Bachelors Degree | Former |
| Mason Wells | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Abbott Diagnostics | President | Current |
| Hycor Biomedical, Inc. | Board of Directors | Current |
| LifeCell Corporation | Board of Directors | Current |
| NABI | Board of Directors | Current |
| Third Wave Technologies, Inc. | Board of Directors | Current |
| Third Wave Technologies, Inc. | Chairman & President | Former |
| Abbott Laboratories | Vice President | Former |
| Abbott Laboratories | Corporate Officer | Former |
| St. Jude Medical, Inc. | Board of Directors | Former |
G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for over 40 years. An early pioneer, Mr. Burrill is one of the original architects of the industry and one of its most avid and sustained developers. He currently serves as Chairman of the Board of Pharmasset (NASDAQ: VRUS) and is a member of the Boards of Directors of Catalyst Biosciences, DepoMed (NASDAQ: DEPO), Intranasal, Phytomedics, Proteogenix, Proventys, Targacept (NASDAQ: TRGT) and XDx. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. In 2002, Mr. Burrill was recognized as the biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50). Mr. Burrill is a founder and currently serves as the Chairman of the Board of the Foundation for the National Medals of Science and Technology. Additionally, he serves as Chairman of the Board on Campaign for Medical Research as well as Chairman of the San Francisco Mayor?s Biotech Advisory Committee (MAYBAC). Other not-for-profit activities include serving on the Boards of Directors for the Bay Area Science Infrastructure Consortium, BayBio, California Healthcare Institute, The Exploratorium, Genetics Policy Institute, The Kellogg Center for Biotechnology, Kramden Institute, The National Health Museum, and Research!America. He also serves as an advisor on the MIT Center for Biomedical Innovation.
| Organization | Position | Status |
|---|---|---|
| Burrill & Company | CEO | Current |
| National Medals | President, Chairman of the Board | Current |
| National Medals | Founder | Current |
| University of California | adjunct professor | Current |
| University of California, San Francisco | Adjunct Professor | Current |
| Pjb Publications, Ltd. | Current | |
| Pyxis Genomics, Inc. | Chairman of the Boards | Current |
| Pharmasset, Inc. | Chairman of the Boards | Current |
| Icoria Inc. | Chairman of the Boards | Current |
| Andrx Corporation | Chairman | Current |
| Bioimagene, Inc. | Chairman | Current |
| Newbridge | Chairman of The Boards | Current |
| Proventys, Inc. | Board of Directors | Current |
| BayBio | Director | Current |
| Bioexec Ventures, LLC | Board of Directors | Current |
| Crosscart, Inc | Board of Directors | Current |
| Pharmasset, Inc. | Board of Directors | Current |
| Clinical Data Inc. | Board of Directors | Current |
| Intranasal Technology, Inc | Board of Directors | Current |
| Kramden Institute | Board Member | Current |
| Depomed, Inc. | Board of Directors | Current |
| Third Wave Technologies, Inc. | Director | Current |
| University of California | Director | Current |
| California Healthcare Institute, Inc. | Board of Directors | Current |
| The National Health Museum, Inc | Treasurer | Current |
| Catalyst Biosciences, Inc. | Board of Directors | Current |
| Proteogenix, Inc. | Board of Directors | Current |
| The Center for Policy On Emerging Technologies, Inc. | Board of Directors | Current |
| Phytomedics, Inc. | Board of Directors | Current |
| Depomed, Inc. | Chief Executive Officer, Burrill & Company | Former |
| Burrill & Company | Founder | Current |
| The Center for Policy On Emerging Technologies, Inc. | CEO, Burrill and Company, San Francisco | Former |
| Pharmasset, Inc. | President and CEO of Pharmasset, Inc. | Former |
| Craves | Founder | Former |
| Icoria Inc. | Board of Directors | Former |
| Ernst & Young | Director | Former |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Tolera Systems LLC | Chief Operating Officer | Current |
| Third Wave Technologies, Inc. | Board of Directors | Current |
| Third Wave Technologies, Inc. | Vice President, Finance | Former |
| University of Chicago | Former |
| Organization | Position | Status |
|---|---|---|
| Third Wave Technologies, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Red Abbey, LLC | Senior Advisor | Current |
| Spinx Technologies | Chairman of the Board | Current |
| Faust Pharmaceuticals Sa | Board of Directors | Current |
| Third Wave Technologies, Inc. | Director | Current |
| Applied Biosystems Group | Co-Founder | Former |
| Hewlett-Packard Company | Manager | Former |
| I-Stat Corp | Board Director | Former |
| Solexa, Inc. | Director | Former |
| University of California | Ph.D | Former |
| University of California, Berkeley | PhD In Biophysical Chemistry | Former |
| University of California, Berkeley | M.A. In Physics | Former |
| University of California | MA | Former |
Executive News
-
Biotech Cools Off in August But Capital Markets Remain Positive
-
Exact Sciences reports second quarter loss
-
Exact Sciences Reports Second-Quarter 2009 Financial Results
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

